Summary

Eligibility
for people ages 22 months to 26 months (full criteria)
Location
at UC Davis
Dates
study started
estimated completion
Principal Investigator
by Mark Underwood, MD (ucdavis)Deb Wright (ucdavis)Satyanarayana Lakshminrusimha, MD (ucdavis)

Description

Summary

An extension of the MINVI trial, the MINVI Follow-Up trial will evaluate the neurodevelopmental outcomes at 22-26 months corrected age of term/near term infants who received UCM or ECC.

Details

The MINVI Follow-up trial will examine the difference in early childhood neurodevelopmental impairment of subjects enrolled in the MINVI trial using standardized neurological and developmental assessments at 22-26 months corrected age.

Keywords

Neurodevelopmental Abnormality Neurodevelopmental impairment Disability Umbilical cord milking Early Cord Clamping Congenital Abnormalities

Eligibility

You can join if…

Open to people ages 22 months to 26 months

  • Enrolled in MINVI trial who survive to 2 years corrected age

You CAN'T join if...

  • Enrolled in MINVI but did not survive to 2 years.

Locations

  • University of California, Davis accepting new patients
    Davis California 95616 United States
  • Sharp Mary Birch Hospital for Women and Newborns accepting new patients
    San Diego California 92123 United States

Lead Scientists at UC Health

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Sharp HealthCare
ID
NCT03621943
Study Type
Interventional
Last Updated